cervical lesions

Inovio says no-go on phase 3 cervical lesion program after clinical setback, lays off 30% of staff
Fierce Biotech
Thu, 08/10/23 - 10:15 am
Inovio Pharmaceuticals
cervical lesions
layoffs
Helix BioPharma Corp. Provides Update on Phase II/III IND Application for Topical Interferon Alpha-2b
MarketWatch
Sat, 11/20/10 - 12:46 pm
Helix BioPharma
topical interferon Alpha-2b
cervical lesions
cervical cancer